Skip to main content
Loading ResearchHub…
Cited by — Abstract No: 228 SIGNIFICANT PROTEINURIA REDUCTION WITH THE ORAL FACTOR B INHIBITOR MY008211A IN IGA NEPHROPATHY: 12-WEEK INTERIM RESULTS FROM A PHASE 2 TRIAL | ResearchHub - ResearchHub